The FDA has granted Fast Track designation to PH94B (aloradine; VistaGen Therapeutics), a central nervous system neuroactive nasal spray for the on-demand treatment of social anxiety disorder.
All articles by Diana Ernst, RPh
-
Latest News Your top articles for Tuesday
For More Personalized News -
Haymarket Medical NetworkTop Picks
-
Spotlight Course
- Loading...
Continuing Medical Education (CME/CE) Courses